Literature DB >> 8427565

Acid phosphatase activity in senile plaques and cerebrospinal fluid of patients with Alzheimer's disease.

R Omar1, M Pappolla, I Argani, K Davis.   

Abstract

The origin of the various components of senile plaques in Alzheimer's disease (AD) continues to be a focus of intense research scrutiny. Lysosomal enzyme activity within the plaques is of particular interest because of its possible relevance to a presumed abnormal processing of precursor molecules that may lead to the formation of plaque amyloid. Histochemical evidence of acid phosphatase (ACP), a lysosomal hydrolase, activity in senile plaques has been documented long before many of the current biochemical data regarding plaque pathogenesis became available. Recent evidence suggests the presence of neuronal membrane abnormalities that may allow "leakage" of some intracellular molecules, including enzymes, into the perineuronal environment and from there, possibly, to the cerebrospinal fluid (CSF). In the course of investigating this hypothesis, we decided to readdress the issue of ACP activity in AD by assaying the enzyme both in brain tissue sections as well as in CSF samples from neuropathologically confirmed cases of AD and from normal control subjects. Brain frozen sections from five cases with AD and five control subjects were histochemically stained for ACP using the alpha-naphthylphosphate hydrolysis method. Frozen CSF samples from 15 cases with AD and 19 control subjects were assayed for ACP activity using the thymolphthalein monophosphate hydrolysis method. In all cases studied, CSFs were cytologically unremarkable. Neurons in normal and AD brains were strongly positive for ACP. In AD, numerous senile plaques showed strong ACP activity with both granular and diffuse patterns. The CSFs from six of 15 AD cases (40%) showed ACP activity with values ranging from 0.04 to 0.4 U/L. No ACP activity was detected in any of the 19 control CSFs analyzed. The exact source of ACP in senile plaques and CSF of patients with AD cannot be established based on these data alone but the ACP may have originated from neurons with oxidative stress or oxygen free radical-mediated membrane damage. The data encourage further investigation of this hypothesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8427565

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

Review 1.  The role of beta-amyloid in the development of Alzheimer's disease.

Authors:  K Ii
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923

Review 2.  Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease.

Authors:  C Glabe
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

3.  Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms.

Authors:  Stacey Melquist; David W Craig; Matthew J Huentelman; Richard Crook; John V Pearson; Matt Baker; Victoria L Zismann; Jennifer Gass; Jennifer Adamson; Szabolcs Szelinger; Jason Corneveaux; Ashley Cannon; Keith D Coon; Sarah Lincoln; Charles Adler; Paul Tuite; Donald B Calne; Eileen H Bigio; Ryan J Uitti; Zbigniew K Wszolek; Lawrence I Golbe; Richard J Caselli; Neill Graff-Radford; Irene Litvan; Matthew J Farrer; Dennis W Dickson; Mike Hutton; Dietrich A Stephan
Journal:  Am J Hum Genet       Date:  2007-03-08       Impact factor: 11.025

4.  [Identification of potential hub genes of Alzheimer's disease by weighted gene co-expression network analysis].

Authors:  J Xue; J Liu; M Geng; J Yue; H He; J Fan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-12-20

Review 5.  Intracellular A-beta amyloid, a sign for worse things to come?

Authors:  Valentina Echeverria; A Claudio Cuello
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.